title: Health impact of smoking and smoking  cessation strategies: current evidence.
abstract: Smoking continues to be the main preventable cause of death in the UK. Tobacco consumption causes a wide range of diseases and other adverse effects, including multiple types of cancer, chronic obstructive pulmonary disease, cardiovascular disease, pregnancy complications, cataracts and osteoporosis. The Government's vision to 'make every contact count' emphasises community nurses' responsibility and key potential to promote healthier living and behaviour. This article reviews the latest evidence on supporting smokers in practice and argues that nurses working in the community are ideally placed to record smoking status, give advice, encouragement and support, refer people to local smoking cessation services and offer pharmacological treatment.
authors.affiliation: Florence Nightingale School of Nursing and Midwifery, King's College London, UK. maria.duaso@kcl.ac.uk
authors.forename: Maria
authors.initials: M
authors.lastname: Duaso
authors.forename: Debbie
authors.initials: D
authors.lastname: Duncan
mesh_terms: D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D002423:Cause of Death; D003376:Counseling; D019317:Evidence-Based Medicine; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use; D024802:Nurse's Role; D011810:Quinoxalines / Q000627:therapeutic use; D012907:Smoking / Q000009:adverse effects* / Q000191:economics / Q000453:epidemiology; D016540:Smoking Cessation; D000074606:Smoking Prevention; D013222:State Medicine; D061485:Tobacco Use Cessation Devices; D006113:United Kingdom / Q000453:epidemiology; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D000068580:Varenicline